These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10064012)

  • 21. Detection of the factor V Leiden mutation in a nonselected black population.
    Pottinger P; Sigurdsson F; Berliner N
    Blood; 1996 Mar; 87(5):2091. PubMed ID: 8634464
    [No Abstract]   [Full Text] [Related]  

  • 22. Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection System.
    Monk SE; Duckworth AW; Farrugia J; Copplestone JA; Rule SA
    Thromb Haemost; 2002 Dec; 88(6):1071-2. PubMed ID: 12529765
    [No Abstract]   [Full Text] [Related]  

  • 23. Activated protein C resistance: a study among 60 thromboembolic patients in the Singapore population.
    Lim LC; Tan HH; Lee LH; Tien SL; Abdul Ghafar A
    Ann Acad Med Singap; 1999 Mar; 28(2):252-5. PubMed ID: 10497677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel DI*A allele without the Band 3-Memphis mutation in Amazonian Indians.
    Baleotti W; Rios M; Reid ME; Fabron A; Pellegrino J; Saad ST; Castilho L
    Vox Sang; 2003 May; 84(4):326-30. PubMed ID: 12757507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombo-embolic disease--prevalence of factor V Leiden in the Western Cape.
    Rubinstein R; Novitzky N
    S Afr Med J; 2001 May; 91(5):406. PubMed ID: 11455804
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C.
    Williamson D; Brown K; Luddington R; Baglin C; Baglin T
    Blood; 1998 Feb; 91(4):1140-4. PubMed ID: 9454742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil antigen (FcgammaRIIIB) SH gene frequencies in six racial groups.
    Hessner MJ; Shivaram SM; Dinauer DM; Curtis BR; Endean DJ; Aster RH
    Blood; 1999 Feb; 93(3):1115-6. PubMed ID: 10025985
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia.
    Prasmusinto D; Skrablin S; Fimmers R; van der Ven K
    Eur J Obstet Gynecol Reprod Biol; 2004 Feb; 112(2):162-9. PubMed ID: 14746952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age and founder effect of SOD1 A4V mutation causing ALS.
    Saeed M; Yang Y; Deng HX; Hung WY; Siddique N; Dellefave L; Gellera C; Andersen PM; Siddique T
    Neurology; 2009 May; 72(19):1634-9. PubMed ID: 19176896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of the activated protein C resistance in indigenous and Black populations of the western Venezuela].
    Vizcaíno G; Torres E; Quintero J; Herrmann F; Grimm R; Diez-Ewald M; Arteaga-Vizcaíno M; Pérez-Requejo JL; Colina-Araujo J
    Invest Clin; 2000 Mar; 41(1):29-36. PubMed ID: 10758697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.
    Camacho Vanegas O; Giusti B; Restrepo Fernandez CM; Abbate R; Pepe G
    Thromb Haemost; 1998 Apr; 79(4):883-4. PubMed ID: 9569213
    [No Abstract]   [Full Text] [Related]  

  • 33. New allele variants of the immunoglobulin switch (Salpha) regions.
    Keyeux G; Bernal JE
    Hum Genet; 1996 May; 97(5):695-6. PubMed ID: 8655157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of testing for factor V Leiden.
    Franchini M
    Blood Transfus; 2012 Jul; 10(3):257-9. PubMed ID: 22889815
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations.
    Gregg JP; Yamane AJ; Grody WW
    Am J Med Genet; 1997 Dec; 73(3):334-6. PubMed ID: 9415695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inherited factor V deficiency associated with a novel heterozygous missense mutation (p.G493R) in a patient with excessive surgical bleeding.
    Kovács KB; Tisza B; Komáromi I; Muszbek L; Bereczky Z
    Thromb Haemost; 2009 Oct; 102(4):787-9. PubMed ID: 19806267
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic Confirmation of Congenital Factor V Deficiency in Korean Patients.
    Park CH; Yoo K; Lee KO; Kim SH; Sung KW; Kim HJ
    Ann Lab Med; 2016 Mar; 36(2):182-4. PubMed ID: 26709270
    [No Abstract]   [Full Text] [Related]  

  • 38. Factor V deficiency caused by a novel missense mutation, Ile417Thr, in the A2 domain.
    Kling SJ; Griffee M; Flanders MM; Rodgers GM
    J Thromb Haemost; 2006 Feb; 4(2):481-3. PubMed ID: 16420587
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation.
    Prüller F; Raggam RB; Mangge H; Truschnig-Wilders M; Matzhold EM; Weiss EC; Hasiba B; Summers KL; Renner W; Siegert G; Kostka H
    Br J Haematol; 2013 Nov; 163(3):414-7. PubMed ID: 23957718
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.